Division News

  • Parsons Named President and CEO of Alliance for Academic Internal Medicine
    Polly Parsons, M.D., E.L. Amidon Chair and Professor of Medicine, has been named the next president and CEO of the Alliance for Academic Internal Medicine.
  • Dixon Named 2022-23 University Scholar
    Anne Dixon, M.A., BM BCh, professor of medicine, has been named one of four 2022-2023 University Scholars.
  • Inaugural Research Week Features Larner Faculty and Trainee Investigation & Innovation
    In celebration of its standing as a top 100 public research university, the University of Vermont held its first “Research Week” April 18 to 22 to showcase the work of faculty, student and trainee investigators. A number of Larner College of Medicine faculty and trainees received recognition and delivered presentations during the week's events.
  • Integrating Mental Health into Pediatric Primary Care
    UVM Pediatric Primary Care is removing barriers to mental health care with an evidence-based Primary Care Mental Health Integration program, piloted with support from the UVM Health Network.
  • Kirkpatrick Presents University Scholar Lecture on Combatting Global Infectious Diseases
    University of Vermont Chair of Microbiology and Molecular Genetics Beth Kirkpatrick, M.D., will present her 2021-22 University Scholar lecture on "Combatting Global Infectious Diseases: Vaccines and Human Models," on Monday, April 4, 2022.
  • CVRI Viridis Montis Challenge Highlights Early-Career Researchers
    Cardiac remodeling, chronic kidney disease, brain cell energy generation, hypertension and stroke risk, and socioeconomic status and cardiac rehabilitation outcomes, were the topics presented at the Cardiovascular Research Institute of Vermont’s annual Viridis Montis Early Career Investigator Challenge on February 2, 2022.
  • New Study Highlights Colorectal Cancer Treatments that Improve Patients' Quality of Life
    In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.
  • Heart Month: Bouncing Back after Atypical Heart Attack
    A heart attack struck 44-year-old Sara Rutledge during her daily run. Thanks to the competence and care of a team of clinicians at Central Vermont Medical Center and UVM Medical Center, she received a diagnosis for spontaneous coronary artery dissection - or SCAD - has had a successful recovery, and is back to doing her favorite activities.
  • Teaching Academy Snow Season Retreat Celebrates Medical Education Excellence
    University of Vermont Larner College of Medicine faculty, leaders, and colleagues gathered virtually for the Teaching Academy’s 2022 Snow Season Education Retreat January 20-21. Highlights of the two-day event included a plenary session by representatives of the Kern National Network for Caring and Character in Medicine, the Induction and Award Ceremony, and an in-person poster session.
  • Adrianzen Herrera Invested as Early Career Green & Gold Professor of Medicine
    In a ceremony held January 12, 2021, an outstanding early career physician-scientist in the University of Vermont’s Larner College of Medicine, Diego Adrianzen Herrera, M.D., was invested as the inaugural holder of the Early Career Green and Gold Professor of Medicine.
  • Carney & Levine Quoted in The Atlantic Article on COVID Surge in VT
    (NOVEMBER 24, 2021) Jan Carney, M.D., M.P.H., associate dean for public health and health policy, and Mark Levine, M.D., Vermont Commissioner of Health and professor of medicine, are both quoted in an article in The Atlantic, titled "America’s Pandemic Star Loses Some Luster," regarding the surge in COVID-19 cases in Vermont.
  • UVM Researchers Help Identify Impact of COVID-caused Delays in Breast Cancer Screening
    New research from U.S. Breast Cancer Surveillance Consortium (BCSC) members, including several University of Vermont researchers, found that from March to September 2020, breast biopsies and detected cancers at U.S. BCSC facilities dropped sharply, compared with the same span a year earlier.
  • UVM Invests Holcombe as Inaugural J. Walter Juckett Chair in Cancer Research
    With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
  • 2021 Celebration of Research Excellence Highlights Accomplishments at Larner
    The University of Vermont’s Larner College of Medicine held a successful Dean's Excellence in Research Celebration October 25-27, shining a light on the hard work and achievements of students, faculty, staff, and alumni.
  • Lahey Pens Opinion Piece on Booster Shots in STAT
    (OCTOBER 15, 2021) Tim Lahey, M.D., M.M.Sc., professor of medicine, authored a "First Opinion" column, titled "Feeling guilty about getting a booster shot? Here’s something you can do." The piece explores the fact that some people are reluctant to receive a booster shot due to vaccine equity issues.
  • 24th Annual Women's Health & Cancer Conference Takes Place Virtually Oct. 1
    The University of Vermont Cancer Center hosted the 24th annual Women’s Health and Cancer Conference on October 1 from 7:30 a.m. to 2:30 p.m. The virtual event, which was free and open to the public, was sponsored by the Victoria Buffum Fund with an aim to empower and support individuals and communities with knowledge about cancer prevention, detection, treatment, and survivorship.
  • Holcombe Quoted in Seven Days Article on Local mRNA Manufacturer
    (AUGUST 25, 2021) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center and Juckett Professor of Cancer Research, commented on the role of mRNA in cancer treatment research.
  • A Search for Meaning
    Bob Gramling, M.D., D.Sc., has witnessed grief in its many forms. As the inaugural Holly and Bob Miller Chair in Palliative Medicine and a professor of family medicine, he counsels seriously ill patients and their families while they navigate the challenging terrain between life and death.
  • King’s Leadership Ushers in Changes to Medical Board Policies on Sexual Misconduct
    Patricia King, M.D., Ph.D., UVM professor of medicine and former chair of the Federation of State Medical Boards (FSMB), led and created the Workgroup on Physician Sexual Misconduct, which conducted a deep review of all available U.S. sexual misconduct disciplinary data, and state medical board physician sexual misconduct laws, policies and procedures might be contributing to this dire problem. Their findings were reported in 2020 and featured in an April 27, 2021 JAMA Viewpoint article.
  • Hearts & Brains: UVM’s Newest COBRE Hits Its Stride at One-Year Anniversary
    Not only is Vermont small and rural, but it’s also old. Currently, the state is ranked fourth in the nation for the relative number of residents over 65 years old – a whopping nearly 20 percent of Vermont’s population and rising. And with that status comes a disproportionately large share of heart disease, as well as blood vessel diseases and brain circulation problems that can lead to dementia and Alzheimer’s disease.